Tag: Johnson & Johnson
FDA Grants Approval to Johnson & Johnson’s IMAAVY for Warm Autoimmune Hemolytic Anemia
Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved IMAAVY® (nipocalimab-aahu) as the first therapy specifically indicated for the...
Johnson & Johnson Secures FDA Approval for Dual-Energy Cardiac Ablation Catheter
Johnson & Johnson has secured U.S. regulatory clearance for its newest electrophysiology device, the Dual Energy THERMOCOOL SMARTTOUCH SF Platform. The system lets doctors...
Johnson & Johnson to acquire Firefly Bio to advance novel cancer treatment
Johnson & Johnson announced that it has entered into a definitive agreement to acquire Firefly Bio, Inc., a privately held biotechnology company specializing in...
